201 - Baseline PSMA PET-Derived SUVmean as a Prognostic Factor for Lesion-Level Metabolic Response to [177Lu]Lu-PSMA-617 In Metastatic Castration-Resistant Prostate Cancer

11:25am - 11:35am ET

Presenter(s)

Nikolai Strusberg, MD - Miami Cancer Institute: Baptist Health South Florida, Miami, FL